Authors
Zhen-Ping Zou, Jing Mi, Shu-Qin Zhou, Ruichao Mao, Xuan-Ren Shi, Wei Du, Jingyu Zhang, Baojun Wang, Lixin Zhang, Bang-Ce Ye, Ying Zhou
Published in
Cell reports. Volume 45. Issue 11. Pages 118314. Nov 17, 2026. Epub Nov 17, 2026.
Abstract
Engineered therapeutic microbes capable of sensing and responding to diseases offer transformative potential for precision medicine. However, their capacity to intelligently process the complex and dynamic biomarkers of multifaceted diseases such as inflammatory bowel disease (IBD) remains limited. Here, we design a probiotic system that executes logic computations through four stage-specific inflammatory biomarkers, enabling precise diagnosis and closed-loop treatment of colitis in mice. Integration with a CRISPR-based molecular recorder allows dynamic tracking of biomarker levels and converts inflammatory signals into quantifiable, site-specific base-editing events, thereby achieving precise diagnosis and analysis of disease progression within a living mammalian gut. We additionally develop a multimodal machine-learning classifier that utilizes both bioluminescent reporter signals and sequencing data to accurately stage intestinal inflammation with an accuracy of 0.83 ± 0.05. Together, this work provides a robust platform for in situ biocomputation and marks a significant advance toward intelligent, precision theranostics for gastrointestinal disorders.
PMID:
43043754
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0